Related content

Hepatic arterial infusion chemotherapy using high-dose 5-fluorouracil and cisplatin with or without interferon-α for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis

By Eun Jong Ryul   Lee Heon Ju   Moon Hee Jung   Kim Tae Nyeun   Kim Jae Woon   Chang Jay Chun  

Scandinavian Journal of Gastroenterology, Vol. 44, Iss. 12, 2009-12 ,pp. : 1477-1486

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and toxicity of fluorouracil, doxorubicin, and cisplatin/nedaplatin treatment as neoadjuvant chemotherapy for advanced esophageal carcinoma

By Kosugi Shin-Ichi   Kanda Tatsuo   Nakagawa Satoru   Ohashi Manabu   Nishimaki Tadashi   Hatakeyama Katsuyoshi  

Scandinavian Journal of Gastroenterology, Vol. 40, Iss. 8, 2005-08 ,pp. : 886-892

Informa Healthcare

Access to resources Recommend Favorite

Retrospective evaluation of adverse events of neoadjuvant or induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in esophageal squamous cell carcinoma

By Sugawara Mitsuhiro  

Esophagus, Vol. 10, Iss. 2, 2013-06 ,pp. : 65-69

Springer Publishing Company

Access to resources Recommend Favorite

Induction Chemotherapy with Docetaxel/Cisplatin/5-Fluorouracil for Patients with Node-Positive Esophageal Cancer

By  

Digestion, Vol. 83, Iss. 3, 2011-01 ,pp. : 146-152

Karger

Access to resources Recommend Favorite

Oxaliplatin/5-Fluorouracil/Leucovorin (FOLFOX4) Regimen as an Adjuvant Chemotherapy in the Treatment of Advanced Jejunal Adenocarcinoma: A Report of 2 Cases

By  

Medical Principles and Practice, Vol. 17, Iss. 6, 2008-10 ,pp. : 496-499

Karger

Access to resources Recommend Favorite